Primary refractory and relapsed adult acute lymphoblastic leukemia: Characteristics, treatment results, and prognosis with salvage therapy

Cancer

Volumn 86, Issue 7, 1999, Pages 1216-1230

  Thomas, Deborah A ^a   Kantarjian, Hagop ^a   Smith, Terry L ^a   Koller, Charles ^a   Cortes, Jorge ^a   O'Brien, Susan ^a   Giles, Francis J ^a   Gajewski, James ^a   Pierce, Sherry ^a   Keating, Michael J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Acute lymphoblastic leukemia; Prognostic factors; Refractory; Relapse; Second induction; Treatment

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REMISSION INDUCTION; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033214233     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991001)86:7<1216::AID-CNCR17>3.0.CO;2-O     Document Type: Article

References (66)

1. Schauer P, Arlin ZA, Mertelsmann R, Cirrincione C, Friedman A, Gee TS, et al. Treatment of acute lymphoblastic leukemia in adults - results of the L-10 and L-10M protocols. J Clin Oncol 1983;1:462-70.
2. Linker CA, Levitt LJ, O'Donnell M, Ries CA, Link MP, Forman SJ, et al. Improved results of treatment of adult acute lymphoblastic leukemia. Blood 1987;69:1242-8.
3. Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811. Blood 1995;85:2025-37.
4. Hoelzer D, Ludwig WD, Thiel E, Gassmann W, Loffler H, Fonatsch C, et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996;87:495-508.
5. Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukemia in adults. Blood 1995;85: 1151-68.
6. Hoelzer DF. Therapy of the newly diagnosed adult with acute lymphoblastic leukemia. Hematol Oncol Clin North Am 1993;7:139-60.
7. Kantarjian HM, Walters R, Keating MJ, Smith TL, O'Brien S, Estey EH, et al. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J Clin Oncol 1990;8:994-1004.
8. Baccarani M, Corbelli G, Amadori S, Drenthe-Schonk A, Willemze R, Meloni G, et al. Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients. Blood 1982;60:677-84.
9. Hoelzer D, Thiel E, Loffler H, Buchner T, Ganser A, Heil G, et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988;71:123-31.
10. Gaynor J, Chapman D, Little C, McKenzie S, Miller W, Andreeff M, et al. A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969. J Clin Oncol 1988;6:1014-30.
11. Chao NJ, Forman SJ, Schmidt GM, Snyder DS, Amylon MD, Konrad PN, et al. Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission. Blood 1991;78:1923-7.
12. Wingard JR, Piantadosi S, Santos GW, Saral R, Vriensendorp HM, Yeager AM, et al. Allogeneic bone marrow transplantation for patients with high risk acute lymphoblastic leukemia. J Clin Oncol 1990;8:820-30.
13. Barrett AJ, Horowitz MM, Ash RC, Atkinson K, Gale RP, Goldman JM, et al. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1992;79:3067-70.
14. Welborn JL. Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults. Am J Hematol 1994;45:341-4.
15. Butturini A, Gale RP. Chemotherapy versus transplantation: II. Acute lymphoblastic leukemia. Haematologica 1989;74: 337-9.
16. Biggs JC, Horowitz MM, Gale RP, Ash RC, Atkinson K, Helbig W, et al. Bone marrow transplantation may cure patients with acute leukemia never achieving remission with chemotherapy. Blood 1992;80:1090-3.
17. Advisory Committee of the International Bone Marrow Transplant Registry: Report from the International Bone Marrow Transplant Registry. Bone Marrow Transplant 1989; 4:221-8.
18. Mortimer J, Blinder MA, Schulman S, Appelbaum FR, Buckner CD, Clift RA, et al. Relapse of acute leukemia after marrow transplantation - natural history and results of subsequent therapy. J Clin Oncol 1989;7:50-7.
19. Cortes J, O'Brien SM, Pierce S, Keating MJ, Freireich EJ, Kantarjian HM. The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia. Blood 1995;86:2091-7.
20. Kantarjian HM, Walters RL, Keating MJ, Estey EH, O'Brien S, Schachner J, et al. Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia. Cancer 1990;65:5-8.
21. Kantarjian HM, Estey EH, O'Brien S, Anaissie E, Beran M, Rios MB, et al. Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemia. Blood 1992;79: 876-81.
22. Suki S, Kantarjian H, Gandhi V, Estey E, O'Brien S, Beran M, et al. Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia. Cancer 1993;72:2155-60.
23. Kantarjian HM, Walters R, Keating MJ, Estey EH, O'Brien S, Schachner J, et al. Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocytic leukemia. Cancer 1989;64:16-22.
24. Koller CA, Kantarjian HM, Thomas D, O'Brien S, Rios MB, Kornblau S, et al. The HCVAD regimen improves outcome in relapsed acute lymphoblastic leukemia. Leukemia 1997;11: 2039-44.
25. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat 1958;53:457-81.
26. Cox DR. Regression models and life tables. J R Stat Soc (B) 1972;34:187-220.
27. Therneau TM. Martingale-based residuals for survival models. Biometrika 1990;77:147-60.
28. Thomas D, Kantarjian H, Koller C, O'Brien S, Keating MJ, Beran M, et al. Review of 43 patients with adult lymphoblastic leukemia in relapse after initial CR duration > 2 years: characteristics, response and outcome with salvage therapy [abstract]. Blood 1997;90:247.
29. Elias L, Shaw MT, Raab SO. Reinduction therapy for adult acute leukemia with Adriamycin, vincristine, and prednisone: a Southwest Oncology Group study. Cancer Treat Rep 1979;63:1413-5.
30. Giona F, Annino L, Rondelli R, Arcese W, Meloni G, Testi AM, et al. Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocol. Br J Haematol 1997;97:896-903.
31. Lobel JS, O'Brien T, McIntosh S, Aspnes GT, Capizzi RL. Methotrexate and asparaginase combination chemotherapy in refractory acute lymphoblastic leukemia of childhood. Cancer 1979;43:1089-94.
32. Esterhay RJ, Wiernik PH, Grove WR, Markus SD, Wesley MN. Moderate dose methotrexate, vincristine, asparaginase, and dexamethasone for treatment of adult acute lymphocytic leukemia. Blood 1982;59:334-45.
33. Woodruff RK, Lister TA, Paxton AM, Whitehouse JMA, Malpas JS. Combination chemotherapy for haematological relapse in adult acute lymphoblastic leukemia. Am J Hematol 1978;4:173-7.
34. Yap BS, McCredie KB, Keating MJ, Bodey GP, Freireich EJ. Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adults. Cancer Treat Rep 1981;65:83-7.
35. Marsh W, Wozniak A, McCarley D. Therapy of relapsed acute lymphocytic leukemia: a 5-year experience with high dose Ara-C [abstract]. Proc Am Soc Clin Oncol 1987;6:147.
36. Kantarjian HM, Estey EH, Plunkett W, Keating MJ, Walters RS, Iacoboni S, et al. Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia. Am J Med 1986;81:387-94.
37. Hiddemann W, Buchner TH, Heil G, Schumacher K, Diedrich H, Maschmeyer G, et al. Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinaoside and mitoxantrone (HAM). Leukemia 1990;4:637-40.
38. Arlin Z, Feldman E, Kempin, S, Ahmed T, Mittelman A, Savana S, et al. Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults. Blood 1988;72:433-5.
39. Montillo M, Tedeschi A, Centurioni R, Leoni P. Treatment of relapsed adult acute lymphoblastic leukemia with fludarabine and cytosine arabinoside followed by granulocyte colony-stimulating factor (FLAG-GCSF). Leuk Lymphoma 1997; 25:579-83.
40. Peterson BA, Bloomfield CD. High-dose methotrexate for the remission induction of refractory adult acute lymphocytic leukemia. Med Pediatr Oncol 1978;5:79-84.
41. Rayan DH, Kopecky KJ, Gumbart CH, Bickers JN. Southwest Oncology Group trial: VM-26 and ifosfamide in refractory adult lymphocytic leukemia [abstract]. Proc Am Soc Clin Oncol 1987;6:143.
42. Keating MJ, Kantarjian H, Smith TL, Estey E, Walters R, Andersson B, et al. Response to salvage therapy and survival after relapse in acute myelogenous leukemia. J Clin Oncol 1989;7:1071-80.
43. Murphy SB, Bowman, WP Abromowitch M, Mirro J, Ochs J, Rivera G, et al. Results of the treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 1986;4:1732-9.
44. Chucrallah AE, Stass SA, Huh YO, Albitar M, Kantarjian HM. Adult acute lymphoblastic leukemia at relapse, cytogenetic, immunophenotypic, and molecular changes. Cancer 1995; 76:985-91.
45. Specchia G, Mininni D, Guerrasio A, Palumbo G, Pastore D, Liso V. Ph-positive acute lymphoblastic leukemia in adults: molecular and clinical studies. Leak Lymphoma 1995; 18(Suppl 1):37-42.
46. Boldt DH, Kopecky K, Head D, Gehly G, Radich J, Appelbaum F. Expression of myeloid antigens in adult acute lymphoblastic leukemia: the Southwest Oncology Group experience [abstract]. Proc Am Soc Clin Oncol 1992;11:263.
47. Guyotat D, Campos L, Shi Z-H, Charin C, Treille D, Magaud JP, et al. Myeloid surface antigen expression in adult lymphoblastic leukemia. Leukemia 1990;4:664-6.
48. Vernant JP, Marit G, Maraninchi D, Guyotat D, Kuentz M, Cordonnier C, et al. Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia during first complete remission. J Clin Oncol 1988;6:227-31.
49. Rowe JM Bone marrow transplantation in first remission. Leukemia 1997;11(Suppl):12-14.
50. Herve P, Bordigoni P, Plouvier E. Chemotherapy versus allogeneic or autologous bone marrow transplantation in second complete remission of acute lymphoblastic leukemia. Leukemia 1992;6(Suppl):59-61.
51. Attal M, Blaise D, Marit G, Payen C, Michallet M, Vernant J P, et al. Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group. Blood 1995;86:1619-28.
52. Horowitz MM, Messerer D, Hoelzer D, Gale RP, Neiss A, Atkinson K, et al. Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Ann Intern Med 1991;115:13-8.
53. Fiere D, Lepage E, Sebban C, Boucheix C, Gisselbrecht C, Vernant JP, et al. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. J Clin Oncol 1993;11: 1990-2001.
54. Stockschlader M, Hegewisch-Becker S, Kruger W, tom Dieck A, Mross K, Hoffknecht M, et al. Bone marrow transplantation for Philadelphia-chromosome positive acute lymphoblastic leukemia. Bone Marrow Transplant 1995;16:663-7.
55. Blume KG, Schmidt GM, Chao NJ, Forman SJ. Bone marrow transplantation from histo-compatible sibling donors for patients with acute lymphoblastic leukemia. Haematol Blood Trans 1990;33:636-7.
56. Blaise D, Attal M, Pico JL, Reiffers J, Stoppa AM, Bellanger C, et al. The use of a sequential high dose recombinant interleukin-2 regimen after autologous bone marrow transplantation does not improve the disease free survival of patients with acute leukemia transplanted in first complete remission. Leuk Lymphoma 1997;25:469-78.
57. Thomas D, Kantarjian H, Cortes J, O'Brien S, Pierce S, Faderl S, et al. The hyper-CVAD program in Burkitt's-type adult acutelymphoblastic leukemia. [abstract]. Blood 1998;92:402.
58. Mehta J, Powles R, Singhal S, Horton C, Tait D, Treleaven J. Melphalan - total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission. Bone Marrow Transplant 1996;18:119-23.
59. Soiffer RJ, Roy DC, Gonin R, Murray C, Anderson KC, Freedman AS, et al. Monoclonal antibody purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse. Bone Marrow Transplant 1993;12:243-51.
60. Brisco J, Hughes E, Neoh SH, Sykes PJ, Bradstock K, Enno A, et al. Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia. Blood 1996;87:5251-6.
61. Gorin NC, Aegerter P, Auvert B. Autologous bone marrow transplantation for acute leukaemia in remission: an analysis on 1322 cases. Haematol Blood Trans 1990;33:660-6.
62. Sallan SE, Niemeyer CM, Billett AL, Lipton JM, Tarbell NJ, Gelber RD, et al. Autologous bone marrow transplantation. J Clin Oncol 1989;7:1594-601.
63. Messinger Y, Levine A, Fuchs E, Goldman F, Uckun FM. B43(anti-CD19)-Genistein treatment of therapy refractory B-lineage acute lymphoblastic leukemia [abstract]. Blood 1998;92:613.
64. Cortes JE, Kantarjian HM. Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy. Cancer 1995;76:2393-417.
65. Preti A, Kantarjian HM. Management of adult acute lymphocytic leukemia: present issues and key challenges. J Clin Oncol 1994;12:1312-22.
66. Pedro Viega J, Afonso H, Sallan SE, Nadler LM, Cardoso AA. Acute lymphoblastic leukemia cells and their bone marrow stroma collaborate to induce endothelial cell proliferation thereby promoting leukemia cell survival [abstract]. Blood 1998;92:511.